| Sarah Cantoni, RN/BSN | |
|
104 Saulsbury Rd, Dover, DE 19904-2705 | |
| (302) 674-0684 | |
| Not Available |
| Full Name | Sarah Cantoni |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - School |
| Location | 104 Saulsbury Rd, Dover, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477886448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | L1-0033624 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Cantoni, RN/BSN 104 Saulsbury Rd, Dover, DE 19904-2705 Ph: (302) 674-0684 | Sarah Cantoni, RN/BSN 104 Saulsbury Rd, Dover, DE 19904-2705 Ph: (302) 674-0684 |
News Archive
Pfizer (PFE) and Crown Bioscience, Inc. (Crown) announced today that they have entered into a collaboration to research and develop novel therapeutics for Asian cancers. Specific treatments for Asian cancers represent an important unmet medical need as well as a significant market opportunity.
The study, published August 9, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, demonstrates that fewer surgeries per year negatively impacted patient standard of care. A free abstract of the study is available at CANCER Online.
Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.
Combining two well-established analytic techniques and adding a twist identifies proteins from blood with as much accuracy and sensitivity as the antibody-based tests used clinically, researchers report this week in Proceedings of the National Academy of Sciences Early Edition online.
Silence Therapeutics plc announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to minimize the off-target effects of RNAi therapeutics is critical for controlling unwanted cellular activity and/or potential safety concerns.
› Verified 6 days ago
Emerald Davis, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1300 S Farmview Dr Apt C24, Dover, DE 19904 Phone: 302-645-3800 | |
Margaret Steinhoff, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 945 Forest St, Dover, DE 19904 Phone: 302-672-1500 | |
Tabitha Erica Herbert, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 198 Commerce Way, Dover, DE 19904 Phone: 302-672-1500 | |
Brett Appelbaum, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 65 Carver Rd, Dover, DE 19904 Phone: 302-672-1620 | |
Nedra Tenley Davidson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1206 Forrest Ave, Dover, DE 19904 Phone: 877-286-5115 | |
Jill Cavalcanti, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 51 Sackarackin Ave, Dover, DE 19901 Phone: 302-645-3300 | |
Matthew S Fuchs, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 150, Dover, DE 19904 Phone: 302-744-6592 Fax: 302-735-3240 |